Helios (NYSE:HLIO) shares dropped 14.6% following an analyst downgrade due to leadership uncertainty. Josef Matosevic placed on leave amid misconduct allegations, with Sean Bagan as Interim CEO. Despite recent turmoil, the stock presents potential buying opportunities.